1. Blood-brain barrier damage in acute multiple sclerosis plaques;Gay, D.; Esiri, M.;Brain,1991
2. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications;Kermode, A.G.; Thompson, A.J.; Tofts, P.;Brain,1990
3. Quantitative MR changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis;Barkhof, F.; Hommes, O.R.; Ph, Scheltens; Valk, J.;Neurology,1991
4. Endothelial cells and inflammation: the role of platelet-activating factor, interleukin 1, tumor necrosis factor and circulating neutrophils;Bussolino, F.; Camussi, G.; Brevario, F.,1988
5. The effects of platelet-activating factor and its specific antagonist BN52021 on the development of experimental allergic encephalomyelitis in rats;Howat, D.W.; Chand, N.; Moore, A.R.; Braquet, P.; Willoughby, D.A.;IntrJ Immunopathol Pharmacol,1988